Zydus receives USFDA approval for Phase2(b)/3 trial of Saroglitazar
Saroglitazar Mg is an investigational compound in the USA, and is yet to be approved by the U.S. Food & Drug Administration (USFDA) or European Medicines Agency (EMA)
Saroglitazar Mg is an investigational compound in the USA, and is yet to be approved by the U.S. Food & Drug Administration (USFDA) or European Medicines Agency (EMA)
Whipple procedure is a very complex operation, mainly performed to remove pancreatic cancer
The NDA for Desidustat is based on positive data from the DREAM-ND and DREAM-D Phase 3 trials in patients with Chronic Kidney Disease (CKD) Not on Dialysis and Dialysis
Nelarabine is in a class of medications called antimetabolites
The group now has 324 approvals and has so far filed over 400 ANDAs
Glycopyrrolate injection can also be used in adults as an adjunctive therapy for the treatment of gastrointestinal ulcer when a rapid effect is desired or when oral medication is not tolerated
Zydus Wellness Limited has reported consolidated financial results for the period ended September 30, 2021
Incidences of Non-alcoholic Fatty Liver Disease (NAFLD) have been rising exponentially worldwide and are associated with co-morbidities including obesity, diabetes, hypertension and metabolic disorders
The rolling submission to the U.S. FDA will begin in the fourth quarter of this year
Zydus' Apremilast tablets are indicated for the treatment of adult patients with moderate to severe plaque psoriasis who are candidates for phototherapy or systemic therapy
Subscribe To Our Newsletter & Stay Updated